CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

NVS Wins FDA Nod for Label Expansion of Immunology Drug Rhapsido

RegulatoryapprovedRhapsidoPositive
AI Analysis

Summary

Novartis received FDA approval for a label expansion of its immunology drug Rhapsido. This regulatory win expands the approved uses of the existing therapy.

Outcome Details

FDA approval for label expansion

Importance:7/10
Sentiment:
0.80
FDA approvallabel expansionimmunologyregulatory
Related Companies

Read the original article

Published by yahoo_finance on October 8, 2026 3:19 PM

Read Original